PROVENT trial puts AZ COVID antibody combo back on trackAstraZeneca’s AZD7442 has shown that it can prevent COVID-19 infection when given to healthy patients – the first Share XPROVENT trial puts AZ COVID antibody combo back on trackhttps://pharmaphorum.com/news/provent-trial-puts-az-covid-antibody-combo-back-on-track/
Roche ‘talking to FDA’ as Alzheimer’s drug moves towards 2022 readoutPhase 3 results with Roche’s amyloid-targeting Alzheimer’s drug gantenerumab may not be due until the second half of Share XRoche ‘talking to FDA’ as Alzheimer’s drug moves towards 2022 readouthttps://pharmaphorum.com/news/roche-talking-to-fda-as-alzheimers-drug-moves-towards-2022-readout/
